lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

A Novel Step-Down Infusion Therapy: Its Safety and Effectiveness in Intracranial Pressure Control Using Barbiturate Therapy

25 Pages Posted: 15 Jan 2019

See all articles by Yukako Yamakawa

Yukako Yamakawa

Kumamoto University - Kumamoto University Hospital

Motohiro Morioka

Kurume University - Department of Neurosurgery

Tetsuya Negoto

Kurume University - School of Medicine

Kimihiko Orito

Kurume University - School of Medicine

Munetake Yoshitomi

Kurume University - School of Medicine

Yukihiko Nakamura

Kurume University - School of Medicine

Nobuyuki Takeshige

Kurume University - School of Medicine

Masafumi Yamamoto

Kurume University - School of Medicine

Yasuharu Takeuchi

Kurume University - School of Medicine

Kazutaka Oda

Kumamoto University - Kumamoto University Hospital

Hirofumi Jono

Kumamoto University - Kumamoto University Hospital

Hideyuki Saito

Kumamoto University - Kumamoto University Hospital

More...

Abstract

Background: Barbiturate therapy has been widely used to suppress increased intracranial pressure (ICP); however, classical barbiturate therapy has disadvantages such as cardiac function depression. This is due to lack of detailed pharmacological dynamics of barbiturate and an established safety infusion method.

Methods: Two healthy male beagles intubated and anesthetized using thiamylal (4·0 mg/kg/h) and propofol (4·0 mg/kg/h) were maintained for 36 h; one dog was maintained under normothermia and the other, hypothermia. A 1·0 mL blood sample was collected at 0, 12, 24, 36, 42, 48 h and drug concentration measured using liquid chromatography-mass spectrometry. Barbiturate therapy was performed at the earliest convenience using the ‘Step-Down Infusion’ method for severe traumatic brain injury patients or sever cerebrovascular disease patients having a Glasgow coma scale 8, and ICP was measured for at least 7 days.

Findings: In the animals, thiamylal concentration increased with time and was influenced by body temperature; the dog with hypothermia had a higher concentration than normothermic dog. Stable values were noted with propofol. In the clinical study, step-down infusion of thiamylal under normothermia resulted in stable concentrations with no abnormal accumulation or threatening changes in serum potassium. Blood pressure was also stable under 25·0 g/mL and no hemodynamic instability was found. ICP increase was inhibited by the increase in thiamylal concentration and cerebral perfusion pressure (CPP) was maintained over 65 mmHg during the time course.

Interpretation: Fixed long-term infusion of barbiturate induced marked drug accumulation, which was enhanced by hypothermia. Our novel “Step-down infusion” method under normothermia can maintain stable, safe thiamylal concentration to achieve both ICP reduction and CPP maintenance without serious side effects such as hypotension or hypokalemia. As the safe maximum concentration of barbiturate remains unclear, further clinical investigation is warranted.

Funding Statement: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Declaration of Interests: All authors declare that no support, financial or otherwise, has been received from any organization that may have an interest in the submitted work, and there are no other relationships or activities that could appear to have influenced the submitted work.

Ethics Approval Statement: All procedures in this study were carried out in strict accordance with the guidelines for animal experimentation at the Animal Research Center of Kurume University. All the animal experiments were reviewed and approved by the Institutional Animal care and use committee (No. P150516). Induction was performed under anesthesia and all efforts made to minimize suffering. The clinical study was reviewed and approved by the Institutional ethical committee of Kurume University (No. 12268).

Suggested Citation

Yamakawa, Yukako and Morioka, Motohiro and Negoto, Tetsuya and Orito, Kimihiko and Yoshitomi, Munetake and Nakamura, Yukihiko and Takeshige, Nobuyuki and Yamamoto, Masafumi and Takeuchi, Yasuharu and Oda, Kazutaka and Jono, Hirofumi and Saito, Hideyuki, A Novel Step-Down Infusion Therapy: Its Safety and Effectiveness in Intracranial Pressure Control Using Barbiturate Therapy (May 1, 2019). Available at SSRN: https://ssrn.com/abstract=3311871

Yukako Yamakawa

Kumamoto University - Kumamoto University Hospital

1 Chome-1-1 Honjo, Chuo Ward
Kumamoto, 860-8556
Japan

Motohiro Morioka (Contact Author)

Kurume University - Department of Neurosurgery ( email )

67 Asahimachi
Kurume, 830-0011
Japan

Tetsuya Negoto

Kurume University - School of Medicine

Kurume
Japan

Kimihiko Orito

Kurume University - School of Medicine

Kurume
Japan

Munetake Yoshitomi

Kurume University - School of Medicine

Kurume
Japan

Yukihiko Nakamura

Kurume University - School of Medicine

Kurume
Japan

Nobuyuki Takeshige

Kurume University - School of Medicine

Kurume
Japan

Masafumi Yamamoto

Kurume University - School of Medicine

Kurume
Japan

Yasuharu Takeuchi

Kurume University - School of Medicine

Kurume
Japan

Kazutaka Oda

Kumamoto University - Kumamoto University Hospital

1 Chome-1-1 Honjo, Chuo Ward
Kumamoto, 860-8556
Japan

Hirofumi Jono

Kumamoto University - Kumamoto University Hospital

1 Chome-1-1 Honjo, Chuo Ward
Kumamoto, 860-8556
Japan

Hideyuki Saito

Kumamoto University - Kumamoto University Hospital

1 Chome-1-1 Honjo, Chuo Ward
Kumamoto, 860-8556
Japan

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
25
Downloads
5